Gayatri BioOrganics files scrutinizer report for 35th AGM

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • Shareholders approved name change to Ananth BioOrganics Limited
  • Sreedhara Reddy Kanaparthi re-designated as Chairman and MD
  • Voting turnout stood at 30.23% of outstanding shares
  • Scrutinizer Vivek Surana & Associates confirmed fair voting process
powered bylight_fuzz_icon
51715284

*this image is generated using AI for illustrative purposes only.

Gayatri BioOrganics Limited shareholders approved a special resolution to change the company's name to Ananth BioOrganics Limited during its 35th Annual General Meeting held on September 23, 2026. The move marks a significant corporate identity shift for the entity.

The meeting, conducted via video conferencing, also ratified the re-designation of Sreedhara Reddy Kanaparthi from Whole-Time Director to Chairman and Managing Director. This change in leadership title was passed alongside other statutory approvals, including the adoption of new Memorandum and Articles of Association compliant with the Companies Act, 2013.

Voting results and attendance

A total of 53 members attended the virtual meeting, representing public non-institutional shareholders. No promoters or promoter group members voted at the AGM, with all votes polled coming from the public category. The total number of shares on record was 78,788,142, of which 23,816,731 shares voted, representing 30.23% of outstanding shares.

Resolution Type Votes In Favour Votes Against Result
Adoption of financial statements Ordinary 23,816,727 4 Passed
Re-appointment of Sreedhara Reddy Kanaparthi Ordinary 23,816,727 4 Passed
Change of name to Ananth BioOrganics Special 23,816,727 4 Passed
Re-designation to Chairman & MD Special 23,816,727 4 Passed
Adoption of new MOA Special 23,816,722 9 Passed
Adoption of new AOA Special 23,816,722 9 Passed

Scrutinizer's report details

M/s. Vivek Surana & Associates, appointed as scrutinizers pursuant to Section 108 of the Companies Act, 2013, submitted their report confirming the fair and transparent conduct of the e-voting process. The remote e-voting window opened on September 20, 2026, at 9:00 am and closed on September 22, 2026, at 5:00 pm. Electronic voting at the AGM remained open for an additional 15 minutes after the meeting concluded at 11:22 am.

The scrutinizer verified that notices were dispatched electronically on September 1, 2026, and advertisements were published in Financial Express (English) and Nava Telangana (Telugu) on September 2, 2026. The cut-off date for voting rights was September 16, 2026. The report confirmed that all electronic data and records were handed over to the Chairman for safekeeping after unblocking the votes in the presence of two witnesses.

Governance and compliance updates

The board adopted new constitutional documents to align with current regulatory frameworks. The re-appointment of Sreedhara Reddy Kanaparthi, who retires by rotation, was approved by ordinary resolution. The company reported that all six resolutions were passed successfully, with negligible dissenting votes recorded across both ordinary and special business items.

The scrutinizer appointed for the voting process was Vivek Surana of M/s. Vivek Surana & Associates. The meeting commenced at 11:00 am and concluded at 11:22 am. The company's statutory auditor, M/s. MGR & Co., and secretarial auditor, M/s. Vivek Surana & Associates, were present virtually.

Historical Stock Returns for Gayatri Bioorganics

1 Day5 Days1 Month6 Months1 Year5 Years
-1.52%+2.78%-0.13%-52.63%-37.62%-24.29%

How will the rebranding to Ananth BioOrganics influence the company's market positioning and brand recognition in the agri-input sector?

What specific strategic initiatives or operational changes are expected under Sreedhara Reddy Kanaparthi's new role as Chairman and Managing Director?

Will the updated Memorandum and Articles of Association enable Gayatri (now Ananth) to pursue new business lines or regulatory opportunities previously restricted?

Gayatri BioOrganics seeks approval for name change, CMD designation at AGM

scanx
Reviewed by
Ashish TScanX News Team
Key Highlights
  • Net loss widened to ₹111.18 lakh in FY26 from ₹72.65 lakh in FY25
  • Zero revenue from operations reported for both fiscal years
  • Shareholders to vote on renaming company to Ananth BioOrganics Limited
  • Sreedhara Reddy Kanaparthi designated as Chairman and Managing Director
  • Non-current borrowings rose sharply to ₹3,523.14 lakh
powered bylight_fuzz_icon
49812713

*this image is generated using AI for illustrative purposes only.

Gayatri BioOrganics will hold its 35th Annual General Meeting on September 23, 2026. The meeting agenda includes a proposed name change to Ananth BioOrganics Limited and a leadership restructuring.

The company reported a net loss of ₹111.18 lakh for FY26, an increase from the ₹72.65 lakh loss recorded in FY25. Revenue from operations remained at zero for both periods.

Corporate Restructuring

Shareholders are being asked to approve a special resolution to change the company’s name from Gayatri BioOrganics Limited to Ananth BioOrganics Limited. The board stated this move aims to reflect new ownership, management structure, and future business objectives without altering the main objects or nature of the business.

Additionally, members are sought to approve the change in designation of Mr. Sreedhara Reddy Kanaparthi from Whole-time Director to Chairman and Managing Director. This appointment is effective from August 5, 2026, for a three-year term initially without remuneration.

Financial Performance

The company did not generate any revenue during FY26 or FY25. The widening loss was driven by higher finance costs and other expenses.

Metric FY26 FY25
Revenue from operations ₹0 ₹0
Finance costs ₹35.77 lakh ₹27.68 lakh
Net loss ₹111.18 lakh ₹72.65 lakh

Total assets stood at ₹171.75 lakh as on March 31, 2026, compared to ₹166.35 lakh in the previous year. Borrowings increased significantly, with non-current borrowings rising to ₹3,523.14 lakh from ₹349.73 lakh.

What the Numbers Show

The surge in borrowings contrasts sharply with the absence of operating revenue. Non-current borrowings grew nearly tenfold year-on-year, while the company continued to report zero income from operations. This indicates that the increase in debt was not funded by operational cash flows but likely through external financing or related-party loans, as noted in the balance sheet disclosures regarding loans from directors and other entities.

Governance Updates

The AGM will also see the re-appointment of Mr. Sreedhara Reddy Kanaparthi as a director. The company has adopted new Memorandum and Articles of Association to align with the Companies Act, 2013. Two independent directors, Mr. Ramachandra Seshaprasad Chodavarapu and Mr. Murali Vittala, resigned during the year citing advancing age, while Mr. Srinivas Iduri was appointed as an independent director.

Historical Stock Returns for Gayatri Bioorganics

1 Day5 Days1 Month6 Months1 Year5 Years
-1.52%+2.78%-0.13%-52.63%-37.62%-24.29%

What specific operational strategy or revenue-generating activities does Ananth BioOrganics plan to implement to address the zero-revenue status in the upcoming fiscal year?

How will the nearly tenfold increase in non-current borrowings impact the company's debt servicing obligations and liquidity position given the absence of operating cash flows?

What is the strategic rationale behind the name change and leadership restructuring, and how does it align with the company's stated future business objectives?

More News on Gayatri Bioorganics

1 Year Returns:-37.62%